Prescriptive Authority of Controlled Substances Drug administrators tend to abuse the prescriptive authority of controlled substances. In the case of advanced practice registered nurse (APRN), Heather Alfonso has been used to demonstrate this (Lisa Chedekel, 2015). She used her position in the Medicare drug program to prescribe controlled substances. Schedule 2 drugs are not supposed to be prescribed by nurse practitioners because it is highly likely that the drugs will be abused. Such issues arise mainly when medical practitioners are willing to compromise their practice by receiving hefty payments to prescribe and administer controlled substances regardless of the rules and regulations. For a medical physician to control the administering of controlled substances, the first step that the physician ensures that a diagnostic workup is conducted. Physicians will have a proper diagnosis of the patients after the diagnostic workup before administering any drug. In the case of Heather Alonso, most of the patients did not have reviews and diagnostic workup before prescriptions and the administration of the drugs which was wrong. The second step a physician should take is obtaining the medical history of the patient and utilizing the prescription database. The database will give information on the drugs the patient has received and will show if other doctors have given multiple medications to the patient (Joel L. Young, 2018). Also necessary is screening for drug-seeking, this will show if the patient is genuine or just abusing drugs. States can improve their prescription drug monitoring programs (PDMP), the better standards will ensure better monitoring and administration of controlled drugs. Any drugs under schedule 2-5 will be monitored. States will be able to learn if stricter control and surveillance are required. Surprise audits at drug administrators can be done through PDMP to check whether the necessary rules and regulations are adhered to. This will lead to efficiency in monitoring and control of administering controlled substances. References Joel L. Young. (2018, June 25). Best practices when prescribing controlled substances. Retrieved from Lisa Chedekel. (2015, April 6). High-prescribing nurse surrenders drug licenses. Retrieved from Purchase the answer to view it

Prescriptive authority of controlled substances is a complex issue that requires careful regulation and monitoring to prevent misuse and abuse. This is particularly important when it comes to advanced practice registered nurses (APRNs) who have the authority to prescribe controlled substances. The case of Heather Alfonso serves as an example of the potential for abuse of this authority (Chedekel, 2015). Alfonso, an APRN, misused her position in the Medicare drug program to prescribe controlled substances inappropriately.

One key issue is the prescription of Schedule 2 drugs by nurse practitioners. These drugs have a high potential for abuse and are tightly controlled. According to the regulations, nurse practitioners are not supposed to prescribe Schedule 2 drugs without proper oversight and strict adherence to protocols. However, some medical practitioners are willing to compromise their practice for financial gain, leading to the abuse of prescriptive authority.

To ensure proper control and administration of controlled substances, physicians should adhere to a systematic approach. The first step is to conduct a diagnostic workup, which involves a comprehensive evaluation of the patient’s condition and medical history. This allows physicians to accurately diagnose the patient’s condition before prescribing any medications.

In Alfonso’s case, many of her patients did not receive proper diagnostic workups before receiving prescriptions and administration of controlled substances. This is a clear violation of the established protocols and puts patients at risk. Diagnostic workups are crucial for ensuring that patients receive the appropriate treatment and that controlled substances are not prescribed unnecessarily.

The second step in the prescribing process is obtaining the patient’s medical history and utilizing prescription databases. These databases provide valuable information on the medications the patient has received in the past and can help identify cases of multiple medication prescribing by different physicians (Young, 2018). This step is important for preventing prescription drug abuse and ensuring patient safety.

In addition, screening for drug-seeking behavior is essential. This involves assessing the patient’s history and behavior for signs of drug abuse or misuse. Physicians need to be vigilant and identify patients who may be seeking prescription drugs for non-medical purposes. Proper screening procedures can help distinguish genuine patients from those who are attempting to abuse controlled substances.

States can play a crucial role in improving prescription drug monitoring programs (PDMPs) to enhance the monitoring and administration of controlled substances. PDMPs can track prescriptions and monitor the usage patterns of controlled drugs. By implementing better standards for PDMPs, states can ensure more effective monitoring and control of these substances.

Stricter monitoring of Schedule 2-5 drugs through PDMPs can provide valuable data for states to assess the level of control needed. Surprise audits of drug administrators can also be conducted through PDMPs to ensure compliance with regulations. By utilizing these tools, states can improve the efficiency and accuracy of monitoring and control efforts.

In conclusion, the prescriptive authority of controlled substances is a sensitive issue, and abuse of this authority can have severe consequences. The case of Heather Alfonso serves as a reminder of the importance of strict adherence to protocols and regulations to prevent misuse and abuse. Adhering to best practices, such as conducting comprehensive diagnostic workups, utilizing prescription databases, and screening for drug-seeking behavior, can help ensure the appropriate and safe administration of controlled substances. Furthermore, states can improve their PDMPs to enhance monitoring and control efforts, ensuring the responsible use of controlled substances.